Monographie - Penicillin G sodium

Utolsó frissítés :
28/04/2024

Penicillin G sodium

Kémiai szerkezet

Kereskedelmi név

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Benapen	Brazília
Bencilpenicilina	Chile, Ecuador, Peru
Benpen	Ausztrália, új-Zéland
Bensylpenicillin	Svédország
Benzapen	Irán
Benzatec	Dél-Afrikai Köztársaság
Benzatron	Brazília
Benzylpenicillin	Dánia, Egyiptom, Finnország, Norvégia, Svédország
Benzylpenicilline	Tunézia
Biconcillina	Ecuador
Crystapen	Írország, Kanada, Nagy-Britannia
Declin	Mexikó
Fortepen	Szaúd-Arábiában
Geepenil	Finnország
Natrium penicillin G	Hollandia
Novopen	Dél-Afrikai Köztársaság
Pebencil	Venezuela
Penbendox	Mexikó
Penibiot	Spanyolország
Penicillin	Norvégia
Penicillina G sodica	Argentína, Chile, Colombia, Ecuador, Portugália
Penilevel	Spanyolország
Sodiopen	Spanyolország
Unicillina	Spanyolország

Irodalom : Penicillin G sodium

	Type	Publikáció
13	Napló	Stiles ML, Allen LV. Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs. Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440	Napló	Stiles ML, Tu YH, Allen LV. Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs. Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057	Napló	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072	Napló	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241	Napló	Rayani S, Jamali F. The stability of penicillin G sodium in 5% dextrose in water minibags after freezing. Can J Hosp Pharm 1985 ; 38: 162-163.
1263	Napló	Allwood MC, Brown PW. The effect of buffering on the stability of reconstituted benzylpenicillin injection. Int J Pharm Pract 1992 ; 1: 242-244.
1725	Napló	Oliver C, Law S. Compatibility of oxytocin, zidovudine, and penicillin G. Can J Hosp Pharm 2001 ; 54: 112-113.
2056	Napló	Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST. Stability of benzylpenicillin during continuous home intravenous therapy. J Antimicrob Chemother 2004 ; 53: 675-677.
2087	Napló	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	Napló	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
3012	Napló	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3227	Napló	Simon B, Hancu G, Gy?resi A. Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520	Laboratórium	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laboratórium	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3540	Laboratórium	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010
3549	Laboratórium	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3580	Laboratórium	Cytarabine Accord - Résumé des caractéristiques du produit Accord Healthcare France 2016
3585	Laboratórium	Benzylpenicillin sodium - Summary of Product Characteristics Genus Pharmaceuticals 2008
3643	Laboratórium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3648	Napló	Hossain M.A, Friciu M, Aubin S, Leclair G. Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers. Am J Health-Syst Pharm 2014 ; 71:669-673.
3674	Laboratórium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3702	Napló	McDougall D.A.J, McWhinney. Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy. J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931	Laboratórium	Trimébutine (Débridat®) - Résumé des caractéristiques du produit Pfizer Laboratoire 2016
3964	Napló	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4154	Laboratórium	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4319	Napló	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	Napló	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4590	Napló	Smith E.K, McWhinney MPhil B.C. Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603	Napló	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.

Mentions Légales